NSCLC - IMMUNOTHERAPY, SCLC AND MESOTHELIOMA
Invited Discussant, Abstracts 1519PD, 1520PD and 1522PD
M. O\'Brien
Invited Discussant, Abstracts 1519PD, 1520PD and 1522PD
M. O\'Brien